Xu Y - Search Results

1

Undetectable minimal residual disease is an independent prognostic factor in splenic marginal zone lymphoma.

Lyu R, Wang T, Wang Y, Xiong W, Wang H, Yan Y, Wang Q, Liu W, An G, Huang W, Sui W, Xu Y, Zou D, Wang J, Qiu L, Yi S. Lyu R, et al. Among authors: xu y. Br J Haematol. 2021 Sep;194(5):862-869. doi: 10.1111/bjh.17703. Epub 2021 Jul 30. Br J Haematol. 2021. PMID: 34328213

2

[Prognostic impact of bone marrow involvement (BMI) and therapies in diffuse large B cell lymphoma].

Yi SH, Xu Y, Zou DH, An G, Zhao YZ, Qi JY, Qiu LG. Yi SH, et al. Among authors: xu y. Zhonghua Xue Ye Xue Za Zhi. 2009 May;30(5):307-12. Zhonghua Xue Ye Xue Za Zhi. 2009. PMID: 19799125 Chinese.

3

Distinct clinical characteristics draw a new prognostic model for splenic marginal zone lymphoma in HBV high prevalent region.

Yi S, Yan Y, Xiong W, Lv R, Yu Z, Liu W, Liu E, Li H, Liu H, Li Z, An G, Xu Y, Ru K, Zou D, Qiu L. Yi S, et al. Among authors: xu y. Oncotarget. 2017 Oct 19;8(58):98757-98770. doi: 10.18632/oncotarget.21931. eCollection 2017 Nov 17. Oncotarget. 2017. PMID: 29228725 Free PMC article.

4

Long-term remissions of young patients with high-risk follicular lymphoma after first-line autologous stem cell transplantation: Three case reports.

Lyu R, Wang T, Zou D, Liu W, Yi S, Huang W, An G, Xu Y, Li Z, Qiu L. Lyu R, et al. Among authors: xu y. Medicine (Baltimore). 2020 May 29;99(22):e20395. doi: 10.1097/MD.0000000000020395. Medicine (Baltimore). 2020. PMID: 32481428 Free article.

5

[The efficacy of thalidomide for multiple myeloma: a clinical analysis of 102 Chinese patients].

Qi PJ, Wang YF, Xu Y, Li YN, Zou DH, Zhao YZ, Xiao ZJ, Qiu LG. Qi PJ, et al. Among authors: xu y. Zhonghua Xue Ye Xue Za Zhi. 2008 Apr;29(4):226-9. Zhonghua Xue Ye Xue Za Zhi. 2008. PMID: 18843974 Chinese.

6

[The Clinical features of myeloma bone disease.].

Li SD, Xu Y, Wang YF, Zhao YZ, Jiang S, Qiu LG. Li SD, et al. Among authors: xu y. Zhonghua Xue Ye Xue Za Zhi. 2010 Apr;31(4):228-32. Zhonghua Xue Ye Xue Za Zhi. 2010. PMID: 20510037 Chinese.

7

[The significances of 13q14 deletion for development and prognosis of multiple myeloma].

Li Q, An G, Li CW, Xu Y, Deng SH, Liu XP, Qi JY, Wang YF, Zou DH, Zhao YZ, Qiu LG. Li Q, et al. Among authors: xu y. Zhonghua Xue Ye Xue Za Zhi. 2011 Apr;32(4):217-20. Zhonghua Xue Ye Xue Za Zhi. 2011. PMID: 21569701 Chinese.

8

[Imatinib combined with modified hyper-CVAD/MA followed by allogeneic hematopoietic stem cell transplantation in CR1 as the front-line therapy for adult Ph(+) acute lymphoblastic leukemia].

Huang J, Zou DH, Fu MW, Li ZJ, Xu Y, Zhao YZ, Qi JY, Qiu LG. Huang J, et al. Among authors: xu y. Zhonghua Xue Ye Xue Za Zhi. 2011 Oct;32(10):673-8. Zhonghua Xue Ye Xue Za Zhi. 2011. PMID: 22339825 Clinical Trial. Chinese.

9

Further stratification of patients with multiple myeloma by International Staging System in combination with ratio of serum free κ to λ light chains.

Xu Y, Sui W, Deng S, An G, Wang Y, Xie Z, Yao H, Zhu G, Zou D, Qi J, Hao M, Zhao Y, Wang J, Chen T, Qiu L. Xu Y, et al. Leuk Lymphoma. 2013 Jan;54(1):123-32. doi: 10.3109/10428194.2012.704033. Epub 2012 Sep 5. Leuk Lymphoma. 2013. PMID: 22712834

10

[Richter syndrome: clinical characteristics and treatment experiences].

Li ZJ, Xu Y, Zhang PH, Liu W, Yi SH, Zou DH, Qi JY, Zhao YZ, Qiu LG. Li ZJ, et al. Among authors: xu y. Zhonghua Yi Xue Za Zhi. 2012 Dec 11;92(46):3254-6. Zhonghua Yi Xue Za Zhi. 2012. PMID: 23328508 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,107 results

Search Page

Filters